Participants' questions:
Are preprints the final article? An earlier stage?
Most of room have published a paper, 2 have posted a preprint
Benefits:
Does it devalue novelty? Eg where you publish?
How is a preprint structured? Is there a criteria for how it should be presented?
Funders have explicit policies now to allow citing preprints on applications
Is the understanding of the use of the preprint evolving?
Could it be a fake news problem?
Number of authors - suspicious if see one only.
Clin sci - medrxiv just launched, expect a more stringent process, journals not yet ready for it
Is there a use of multiple servers?
Can you publish negative findings?
Is there a standard for preprints? ASAPbio are trying to establish standard. Matters to funders as need to know directory of reputable preprint servers.
Cell press sneak peek preview - bad behaviour, a (free) subscription journal club on mendeley. Do funders want to know if preprints are open.
Advantage of preprints = rapid feedback but who reads them?
Word of mouth recommendations
There are subject lists by email
Twitter is huge
Impact of preprints - data of downloads as preprints versus impact of paper yet
PLoS genetics know have preprint editors, turns it into marketplace
You could tweet with a good video, etc versus asking others to tweet
OA nature of preprints, why pay to publish OA?